Page 184 - 2022 Ranger Medic Handbook
P. 184

PLASMA-LYTE A
         Class: Plasma volume expander – crystalloid; isotonic salt solution
         Action: Sterile, nonpyrogenic isotonic solution. Each 100mL contains 526mg of sodium chloride, USP (NaCl); 502mg
         of sodium gluconate (C 6 H 11 NaO 7 ); 368mg of sodium acetate trihydrate, USP (C 2 H 3 NaO 23 H 2 O); 37mg of potassium
         chloride, USP (KCl); and 30mg of magnesium chloride, USP (MgCl 26 H 2 O).
         Dose: 500–1,000mL IV
         Indications: A source of water and electrolytes or as an alkalinizing agent. Plasma-Lyte A is compatible with blood
         or blood components
         Contraindications: Known hypersensitivity of the product.
         Adverse/Side-effects: Peripheral/pulmonary edema, anaphylactic reaction, and the following manifestations: tachy-
         cardia, palpitations, chest pain, chest discomfort, dyspnea, respiratory rate increased, flushing, hyperemia, asthenia,
         feeling abnormal, piloerection, edema peripheral, pyrexia; infusion site reactions
         Interactions: Caution is advised when administering to patients treated with drugs that may increase the risk of so-
         dium and fluid retention, such as corticosteroids or patients with congestive heart failure
    SECTION 4  POLYETHYLENE GLYCOL (MIRALAX)



         Class: Osmotic laxative
         Action: Increases water in the stool resulting in softer stool and increased frequency of bowel movements
         Dose: 17g (1 heaping tablespoon) dissolved in 8oz of beverage once daily as needed
         Indications: Occasional constipation
         Contraindications:  Hypersensitivity, bowel obstruction, renal disease, pregnancy category may use during preg-
         nancy and while breastfeeding
         Adverse/Side-effects: Diarrhea, abdominal bloating, abdominal pain, nausea, cramping
         Mission Impact: None


         PREDNISONE
         Class: Systemic corticosteroid
         Action: Synthetic glucocorticoid; controls/prevents inflammation by governing the rate of protein synthesis, suppress-
         ing migration of leukocytes, reversing capillary permeability and stabilizing lysosomes
         Dose: Asthma attack or post anaphylaxis: 60mg PO per day × 4–5 days. Tapered dosing (systemic poison ivy, other
         anaphylactoid reactions) – 60mg PO per day (days 1–5), 40mg PO per day (days 6–10), 20mg PO per day (days 11–15)
         Indications: Asthma, anaphylaxis or other systemic swelling/edema
         Contraindications: Hypersensitivity, systemic fungal infections, peptic ulcers, hypertension, osteoporosis, pregnancy
         category consider alternative during pregnancy and may use while breastfeeding
         Side-effects: Bradycardia, CHF, edema, euphoria, headache, nausea, vomiting, peptic ulcer, muscle weakness, de-
         layed wound healing, hypertension
         Interactions: Barbiturates, diuretics; may inhibit antibody response to live vaccines or toxoids; may inhibit efficacy
         of hormonal birth control
         Mission Impact: None




        170      SECTION 4   RANGER MEDIC PHARMACOLOGY & FORMULARY
   179   180   181   182   183   184   185   186   187   188   189